Professor Liu Xinyu’s experience in treating dyslipidemia based on the theory of “phlegm turbidity”
WANG Huihui1 LIU Xinyu2
1.The First Clinical College of Medicine, Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250399, China;
2.the Second Department of Cardiology, Linyi Hospital of Traditional Chinese Medicine, Shandong Province, Linyi 276002, China
Abstract：Dyslipidemia is a common metabolic disease in clinic. Its incidence is relatively hidden, and it is often detected by standard biochemical examination. It can cause atherosclerotic cardio cerebrovascular disease and increase the risk of tumor. The phlegm turbid theory is an important part of the etiology theory of traditional Chinese medicine, it has been playing a new and important role in the differentiation and treatment of dyslipidemia for many years. Professor Liu Xinyu has rich experience in the treatment of dyslipidemia with the combination of traditional Chinese and western medicine, he believes that the main pathogenesis of dyslipidemia is phlegm endogenous and blocking qi, according to the pathogenesis, he puts forward that according to the difference of deficiency and excess yin and yang of the lung, spleen, and kidney, from the extension of phlegm turbidity theory, he applies a variety of traditional Chinese medicine treatment methods, which reflects the characteristics of “not limited to surgery” in traditional Chinese medicine treatment. Based on the theory of “phlegm turbid” theory, professor Liu Xinyu has achieved good clinical results in the treatment of dyslipidemia.
王惠惠1 刘新宇2. 刘新宇教授基于“痰浊”理论辨治血脂异常经验[J]. 中国医药导报, 2023, 20(4): 139-142.
WANG Huihui1 LIU Xinyu2. Professor Liu Xinyu’s experience in treating dyslipidemia based on the theory of “phlegm turbidity”. 中国医药导报, 2023, 20(4): 139-142.
京公网安备 11010502046598号